EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer
Daniela D’Agostino(McGill University Health Centre), Gianluca Sala(University of Chieti-Pescara)
Cited by 12
Related Papers
A Novel Recurrent <i>COL5A1</i> Genetic Variant Is Associated With a Dysplasia-Associated Arterial Disease Exhibiting Dissections and Fibromuscular Dysplasia
|Arteriosclerosis Thrombosis and Vascular Biology|2020|48
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma
|Journal of Controlled Release|2018|38
ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs)
|Oncotarget|2015|36